azelastine hydrochloride and fluticasone propionate
Generic: azelastine hydrochloride and fluticasone propionate
Labeler: apotex corp.Drug Facts
Product Profile
Brand Name
azelastine hydrochloride and fluticasone propionate
Generic Name
azelastine hydrochloride and fluticasone propionate
Labeler
apotex corp.
Dosage Form
SPRAY, METERED
Routes
Active Ingredients
azelastine hydrochloride 137 ug/1, fluticasone propionate 50 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
60505-0953
Product ID
60505-0953_2a316a42-19b9-2939-cda9-71111b40a4c4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207712
Listing Expiration
2026-12-31
Marketing Start
2020-03-02
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
605050953
Hyphenated Format
60505-0953
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
azelastine hydrochloride and fluticasone propionate (source: ndc)
Generic Name
azelastine hydrochloride and fluticasone propionate (source: ndc)
Application Number
ANDA207712 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 137 ug/1
- 50 ug/1
Packaging
- 1 BOTTLE, SPRAY in 1 CARTON (60505-0953-3) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "2a316a42-19b9-2939-cda9-71111b40a4c4", "openfda": {"unii": ["0L591QR10I", "O2GMZ0LF5W"], "rxcui": ["1797847"], "spl_set_id": ["7bbc6514-bea3-0be0-e673-a8f6069025ff"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, SPRAY in 1 CARTON (60505-0953-3) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY", "package_ndc": "60505-0953-3", "marketing_start_date": "20200302"}], "brand_name": "Azelastine hydrochloride and Fluticasone propionate", "product_id": "60505-0953_2a316a42-19b9-2939-cda9-71111b40a4c4", "dosage_form": "SPRAY, METERED", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "60505-0953", "generic_name": "Azelastine hydrochloride and Fluticasone propionate", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azelastine hydrochloride and Fluticasone propionate", "active_ingredients": [{"name": "AZELASTINE HYDROCHLORIDE", "strength": "137 ug/1"}, {"name": "FLUTICASONE PROPIONATE", "strength": "50 ug/1"}], "application_number": "ANDA207712", "marketing_category": "ANDA", "marketing_start_date": "20200302", "listing_expiration_date": "20261231"}